This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Jan;86(1):16-23.

doi: 10.1210/jcem.86.1.7269.

Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy

R J Santen¹, J Pinkerton, C McCartney, G R Petroni

Affiliations

PMID: 11231971
DOI: 10.1210/jcem.86.1.7269

Review

Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy

R J Santen et al. J Clin Endocrinol Metab. 2001 Jan.

. 2001 Jan;86(1):16-23.

doi: 10.1210/jcem.86.1.7269.

Authors

R J Santen¹, J Pinkerton, C McCartney, G R Petroni

Affiliation

¹ University of Virginia Health System, Departments of Medicine, Charlottesville, Virginia 22908, USA.

PMID: 11231971
DOI: 10.1210/jcem.86.1.7269

No abstract available

PubMed Disclaimer

Similar articles

Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F. Campagnoli C, et al. J Steroid Biochem Mol Biol. 2005 Jul;96(2):95-108. doi: 10.1016/j.jsbmb.2005.02.014. J Steroid Biochem Mol Biol. 2005. PMID: 15908197 Free PMC article. Review.
Breast cancer and hormone-replacement therapy: the Million Women Study.
Garton M. Garton M. Lancet. 2003 Oct 18;362(9392):1328; author reply 1330-1. doi: 10.1016/S0140-6736(03)14590-4. Lancet. 2003. PMID: 14575985 No abstract available.
[Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B. von Schoultz B. Lakartidningen. 2009 Aug 19-25;106(34):2041-2. Lakartidningen. 2009. PMID: 19769143 Swedish. No abstract available.
Hormone replacement therapy and the risk of breast cancer.
Cuzick J. Cuzick J. Eur J Cancer. 2008 Nov;44(16):2344-9. doi: 10.1016/j.ejca.2008.07.041. Epub 2008 Sep 8. Eur J Cancer. 2008. PMID: 18783940 Review.
More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Magnusson C, Persson I, Adami HO. Magnusson C, et al. J Natl Cancer Inst. 2000 Jul 19;92(14):1183-4. doi: 10.1093/jnci/92.14.1183. J Natl Cancer Inst. 2000. PMID: 10904095 No abstract available.

See all similar articles

Cited by

Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer.
Katuwal S, Tapanainen J, Pukkala E. Katuwal S, et al. Breast Cancer Res Treat. 2022 Jun;193(2):495-505. doi: 10.1007/s10549-022-06571-x. Epub 2022 Apr 2. Breast Cancer Res Treat. 2022. PMID: 35366162 Free PMC article.
Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies.
Wang K, Li F, Chen L, Lai YM, Zhang X, Li HY. Wang K, et al. Oncotarget. 2017 Aug 11;8(46):81109-81124. doi: 10.18632/oncotarget.20154. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113371 Free PMC article.
The effects of tualang honey on bone metabolism of postmenopausal women.
Mohd Effendy N, Mohamed N, Muhammad N, Mohamad IN, Shuid AN. Mohd Effendy N, et al. Evid Based Complement Alternat Med. 2012;2012:938574. doi: 10.1155/2012/938574. Epub 2012 Aug 29. Evid Based Complement Alternat Med. 2012. PMID: 22973408 Free PMC article.
Progestins and progesterone in hormone replacement therapy and the risk of breast cancer.
Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F. Campagnoli C, et al. J Steroid Biochem Mol Biol. 2005 Jul;96(2):95-108. doi: 10.1016/j.jsbmb.2005.02.014. J Steroid Biochem Mol Biol. 2005. PMID: 15908197 Free PMC article. Review.
Medroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.
Pazol K, Wilson ME, Wallen K. Pazol K, et al. J Clin Endocrinol Metab. 2004 Jun;89(6):2998-3006. doi: 10.1210/jc.2003-032086. J Clin Endocrinol Metab. 2004. PMID: 15181090 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information